 Kansas City Star |
Merck pares 2010 forecast, despite beat in quarter
Reuters N) issued a more cautious 2010 profit outlook on Friday and reported disappointing second-quarter sales of its vaccines and Singulair asthma drug, … Merck 2Q Profit Drops 52% On Charges; Key Drug Sales Weaker Merck's profit drops on merger costs, revamp Merck's 2Q net drops on higher costs, charges |
View full post on asthma – Google News